The Dual Role Played by p21 May Influence the Apoptotic or Anti-Apoptotic Fate in Cancer
DOI:
https://doi.org/10.6000/1929-2279.2012.01.02.5Keywords:
p21, Tumourigenesis, Cell cycle arrest, Apoptosis, Subcellular localization.Abstract
p21 is a cyclin-dependent kinase inhibitor that is activated in response to different stress stimuli and could act as cell cycle suppressor. p21 can bind and inhibit cyclin-dependent kinase/cyclin complexes to mediate growth arrest in G1 and G2 phases. This condition enables DNA repair and suggests that p21 could have a role of tumour suppressor. p21 is one of the transcriptional targets of p53, a protein up-regulated after cellular stress stimuli. Besides the classical p53-dependent activation, p21 transcription can be achieved by other regulators as Sp1, STAT and AP2 in a p53-independent manner. Depending on cell type and cellular conditions p21 can have anti-apoptotic or pro-apoptotic functions being involved either in tumourigenesis or in tumour suppression. The function exerted is based on subcellular localization. In the nucleus p21 inhibits proliferation by blocking the cyclin dependent kinases while in the cytoplasm it acts inhibiting pro-apoptotic protein determining cell death inhibition. The different subcellular localization is related to different prognostic role of p21 in cancer and the cellular context in which it is expressed determines if it can be considered as a specific therapeutic target or as a marker of poor prognosis. This review focuses on the recent understanding of the functions of p21 with particular attention to the dual role detected in cancer where p21 can act as tumour suppressor promoting apoptosis or as oncogene preventing it.
References
Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501-12. http://dx.doi.org/10.1101/gad.13.12.1501
Bates S, Ryan KM, Phillips AC, Vousden, KH. Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression. Oncogene 1998; 17: 1691-703. http://dx.doi.org/10.1038/sj.onc.1202104
Gulbis JM, Kelman Z, Hurwitz J, O'Donnell M, Kuriyan J. Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA. Cell 1996; 87: 297-306. http://dx.doi.org/10.1016/S0092-8674(00)81347-1
Komiya T, Hosono Y, Hirashima T, Masuda N, Yasumitsu T, Nakagawa K, et al. p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung. Clin Cancer Res 1997; 3: 1831-5.
Zirbes TK, Baldus SE, Moenig SP, Nolden S, Kunze D, Shafizadeh ST, et al. Prognostic impact of p21/waf1/cip1 in colorectal cancer. Int J Cancer 2000; 89: 14-8. http://dx.doi.org/10.1002/(SICI)1097-0215(20000120)89:1<14::AID-IJC3>3.0.CO;2-L
Martin-Caballero J, Flores JM, Garcia-Palencia P, Serrano M. Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res 2001; 61: 6234-8.
Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinichenko TV, et al. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci USA 2000; 97: 4291-6. http://dx.doi.org/10.1073/pnas.97.8.4291
Chen J, Saha P, Kornbluth S, Dynlacht BD, Dutta A. Cyclin-binding motifs are essential for the function of p21CIP1. Mol Cell Biol 1996; 16: 4673-82.
Saha P, Eichbaum Q, Silberman ED, Mayer BJ, Dutta A. p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases. Mol Cell Biol 1997; 17: 4338-45.
Delavaine L, La Thangue NB. Control of E2F activity by p21Waf1/Cip1. Oncogene 1999; 18: 5381-92. http://dx.doi.org/10.1038/sj.onc.1202923
Afshari CA, Nichols MA, Xiong Y, Mudryj M. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Cell Growth Differ 1996; 7: 979-88.
Charrier-Savournin FB, Chateau MT, Gire V, Sedivy J, Piette J, Dulic V. p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress. Mol Biol Cell 2004; 15: 3965-76. http://dx.doi.org/10.1091/mbc.E03-12-0871
Lee J, Kim JA, Barbier V, Fotedar A, Fotedar R. DNA damage triggers p21WAF1-dependent Emi1 down-regulation that maintains G2 arrest. Mol Biol Cell 2009; 20: 1891-902. http://dx.doi.org/10.1091/mbc.E08-08-0818
Kitaura H, Shinshi M, Uchikoshi Y, Ono T, Iguchi-Ariga SM, Ariga H. Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J Biol Chem 2000; 275: 10477-83. http://dx.doi.org/10.1074/jbc.275.14.10477
Garcia-Wilson E, Perkins ND. p21WAF1/CIP1 regulates the p300 sumoylation motif CRD1 through a C-terminal domain independently of cyclin/CDK binding. Cell Cycle 2005; 4: 1113-9. http://dx.doi.org/10.4161/cc.4.8.1885
Zhang Y, Fujita N, Tsuruo T. Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene 1999; 18: 1131-8. http://dx.doi.org/10.1038/sj.onc.1202426
Martinez LA, Yang J, Vazquez ES, Rodriguez-Vargas Mdel C, Olive M, Hsieh JT, et al. p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells. Carcinogenesis 2002; 23: 1289-96. http://dx.doi.org/10.1093/carcin/23.8.1289
Forster K, Obermeier A, Mitina O, Simon N, Warmuth M, Krause G, et al. Role of p21(WAF1/CIP1) as an attenuator of both proliferative and drug-induced apoptotic signals in BCR-ABL-transformed hematopoietic cells. Ann Hematol 2008; 87: 183-93. http://dx.doi.org/10.1007/s00277-007-0400-9
Fan Y, Borowsky AD, Weiss RH. An antisense oligodeoxynucleotide to p21(Waf1/Cip1) causes apoptosis in human breast cancer cells. Mol Cancer Ther 2003; 2: 773-82.
Moon DO, Choi YH, Kim GY. Role of p21 in SP600125-induced cell cycle arrest, endoreduplication, and apoptosis. Cell Mol Life Sci 2011; 68: 3249-60. http://dx.doi.org/10.1007/s00018-011-0626-5
Xu SQ, El-Deiry WS. p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4. Biochem Biophys Res Commun 2000; 269: 179-90. http://dx.doi.org/10.1006/bbrc.2000.2247
Kondo S, Barna BP, Kondo Y, Tanaka Y, Casey G, Liu J, et al. WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis. Oncogene 1996; 13: 1279-85.
Lincet H, Poulain L, Remy JS, Deslandes E, Duigou F, Gauduchon P, et al. The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. Cancer Lett 2000; 161: 17-26. http://dx.doi.org/10.1016/S0304-3835(00)00586-3
Baldi A, Piccolo MT, Boccellino MR, Donizetti A, Cardillo I, La Porta R, et al. Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma. PLoS One 2011; 6: e23569. http://dx.doi.org/10.1371/journal.pone.0023569
Spugnini EP, Cardillo I, Verdina A, Crispi S, Saviozzi S, Calogero R, et al. Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma. Clin Cancer Res 2006; 12: 6133-43. http://dx.doi.org/10.1158/1078-0432.CCR-06-1056
Agrawal S, Agarwal ML, Chatterjee-Kishore M, Stark GR, Chisolm GM. Stat1-dependent, p53-independent expression of p21(waf1) modulates oxysterol-induced apoptosis. Mol Cell Biol 2002; 22: 1981-92. http://dx.doi.org/10.1128/MCB.22.7.1981-1992.2002
Sheikh MS, Rochefort H, Garcia M. Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene 1995; 11: 1899-905.
Choi YH, Yoo YH. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells. Oncol Rep 2012; 28: 2163-9.
Suzuki T, Yokozaki H, Kuniyasu H, Hayashi K, Naka K, Ono S, et al. Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines. Int J Cancer 2000; 88: 992-7. http://dx.doi.org/10.1002/1097-0215(20001215)88:6<992::AID-IJC24>3.0.CO;2-9
Richon VM, Sandhoff TW, Rifkind RA, Marks PA. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci USA 2000; 97: 10014-9. http://dx.doi.org/10.1073/pnas.180316197
Gui CY, Ngo L, Xu WS, Richon VM, Marks PA. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc Natl Acad Sci USA 2004; 101: 1241-6. http://dx.doi.org/10.1073/pnas.0307708100
Huang H, Liu N, Guo H, Liao S, Li X, Yang C, et al. L-Carnitine Is an Endogenous HDAC Inhibitor Selectively Inhibiting Cancer Cell Growth In vivo and In vitro. PLoS One 2012; 7: e49062. http://dx.doi.org/10.1371/journal.pone.0049062
Ryazantseva NV, Novitskii VV, Zhukova OB, Biktasova AK, Chechina OE, Sazonova EV, et al. Role of NF-kB, p53, and p21 in the regulation of TNF-alpha mediated apoptosis of lymphocytes. Bull Exp Biol Med 2010; 149: 50-3. http://dx.doi.org/10.1007/s10517-010-0873-8
Lee RH, Yoon N, Reneau JC, Prockop DJ. Preactivation of Human MSCs with TNF-alpha Enhances Tumor-Suppressive Activity. Cell Stem Cell 2012. http://dx.doi.org/10.1016/j.stem.2012.10.001
Wu Q, Kirschmeier P, Hockenberry T, Yang TY, Brassard DL, Wang L, et al. Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells. J Biol Chem 2002; 277: 36329-37. http://dx.doi.org/10.1074/jbc.M204962200
Tsao YP, Huang SJ, Chang JL, Hsieh JT, Pong RC, Chen, SL. Adenovirus-mediated p21((WAF1/SDII/CIP1)) gene transfer induces apoptosis of human cervical cancer cell lines. J Virol 1999; 73: 4983-90.
Kang KH, Kim WH, Choi KH. p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells. Exp Cell Res 1999; 253: 403-12. http://dx.doi.org/10.1006/excr.1999.4644
el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-25. http://dx.doi.org/10.1016/0092-8674(93)90500-P
Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995; 9: 935-44. http://dx.doi.org/10.1101/gad.9.8.935
Biggs JR, Kudlow JE, Kraft AS. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J Biol Chem 1996; 271: 901-6. http://dx.doi.org/10.1074/jbc.271.2.901
De Siervi A, Marinissen M, Diggs J, Wang XF, Pages G, Senderowicz A. Transcriptional activation of p21(waf1/cip1) by alkylphospholipids: role of the mitogen-activated protein kinase pathway in the transactivation of the human p21(waf1/cip1) promoter by Sp1. Cancer Res 2004; 64: 743-50. http://dx.doi.org/10.1158/0008-5472.CAN-03-2505
Ocker M, Schneider-Stock R. Histone deacetylase inhibitors: signalling towards p21cip1/waf1. Int J Biochem Cell Biol 2007; 39: 1367-74. http://dx.doi.org/10.1016/j.biocel.2007.03.001
Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995; 267: 1018-21. http://dx.doi.org/10.1126/science.7863327
Guo K, Wang JA, Andres V, Smith RC, Walsh K. Myod-Induced Expression of P21 Inhibits Cyclin-Dependent Kinase-Activity Upon Myocyte Terminal Differentiation. Mol Cell Biol 1995; 15: 3823-9.
Puri PL, Avantaggiati ML, Balsano C, Sang NL, Graessmann A, Giordano A, et al. P300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J 1997; 16: 369-83. http://dx.doi.org/10.1093/emboj/16.2.369
Ishido M, Kami K, Masuhara M. In vivo expression patterns of MyoD, p21, and Rb proteins in myonuclei and satellite cells of denervated rat skeletal muscle. Am J Physiol-Cell Ph 2004; 287: C484-C93. http://dx.doi.org/10.1152/ajpcell.00080.2004
Mutoh H, Naya FJ, Tsai MJ, Leiter AB. The basic helix-loop-helix protein BETA2 interacts with p300 to coordinate differentiation of secretin-expressing enteroendocrine cells. Gene Dev 1998; 12: 820-30. http://dx.doi.org/10.1101/gad.12.6.820
Wajapeyee N, Somasundaram K. Cell cycle arrest and apoptosis induction by activator protein 2alpha (AP-2alpha) and the role of p53 and p21WAF1/CIP1 in AP-2alpha-mediated growth inhibition. J Biol Chem 2003; 278: 52093-101. http://dx.doi.org/10.1074/jbc.M305624200
Radhakrishnan SK, Feliciano CS, Najmabadi F, Haegebarth A, Kandel ES, Tyner AL, et al. Constitutive expression of E2F-1 leads to p21-dependent cell cycle arrest in S phase of the cell cycle. Oncogene 2004; 23: 4173-6. http://dx.doi.org/10.1038/sj.onc.1207571
Chin YE, Kitagawa M, Su WC, You ZH, Iwamoto Y, Fu XY. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 1996; 272: 719-22. http://dx.doi.org/10.1126/science.272.5262.719
Yang X, Wang W, Qin JJ, Wang MH, Sharma H, Buolamwini JK, et al. JKA97, a novel benzylidene analog of harmine, exerts anti-cancer effects by inducing G1 arrest, apoptosis, and p53-independent up-regulation of p21. PLoS One 2012; 7: e34303. http://dx.doi.org/10.1371/journal.pone.0034303
Yi X, Hong M, Gui B, Chen Z, Li L, Xie G, et al. RNA processing and modification protein, carbon catabolite repression 4 (Ccr4), arrests the cell cycle through p21-dependent and p53-independent pathway. J Biol Chem 2012; 287: 21045-57. http://dx.doi.org/10.1074/jbc.M112.355321
Garcia-Fernandez RA, Garcia-Palencia P, Sanchez MA, Gil-Gomez G, Sanchez B, Rollan E, et al. Combined loss of p21(waf1/cip1) and p27(kip1) enhances tumorigenesis in mice. Lab Invest 2011; 91: 1634-42. http://dx.doi.org/10.1038/labinvest.2011.133
Kapranos N, Stathopoulos GP, Manolopoulos L, Kokka E, Papadimitriou C, Bibas A, et al. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value. Anticancer Res 2001; 21: 521-8.
Mitomi H, Mori A, Kanazawa H, Nishiyama Y, Ihara A, Otani Y, et al. Venous invasion and down-regulation of p21(WAF1/CIP1) are associated with metastasis in colorectal carcinomas. Hepatogastroenterology 2005; 52: 1421-6.
Ozcelik H, Mousses S, Andrulis IL. Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations. Clin Cancer Res 1995; 1: 907-12.
Elbendary AA, Cirisano FD, Evans AC Jr., Davis PL, Iglehart JD, Marks JR, et al. Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells. Clin Cancer Res 1996; 2: 1571-5.
Akashi M, Hachiya M, Osawa Y, Spirin K, Suzuki G, Koeffler HP. Irradiation Induces Waf1 Expression through a P53-Independent Pathway in Kg-1 Cells. J Biol Chem 1995; 270: 19181-7. http://dx.doi.org/10.1074/jbc.270.32.19181
Baretton GB, Klenk U, Diebold J, Schmeller N, Lohrs U. Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression. Br J Cancer 1999; 80: 546-55. http://dx.doi.org/10.1038/sj.bjc.6690390
Ferrandina G, Stoler A, Fagotti A, Fanfani F, Sacco R, De Pasqua A, et al. p21WAF1/CIP1 protein expression in primary ovarian cancer. Int J Oncol 2000; 17: 1231-5.
Cheung TH, Lo KW, Yu MM, Yim SF, Poon CS, Chung, TK, et al. Aberrant expression of p21(WAF1/CIP1) and p27(KIP1) in cervical carcinoma. Cancer Lett 2001; 172: 93-8. http://dx.doi.org/10.1016/S0304-3835(01)00624-3
Ceccarelli C, Santini D, Chieco P, Lanciotti C, Taffurelli M, Paladini G, et al. Quantitative p21(waf-1)/p53 immunohistochemical analysis defines groups of primary invasive breast carcinomas with different prognostic indicators. Int J Cancer 2001; 95: 128-34. http://dx.doi.org/10.1002/1097-0215(20010320)95:2<128::AID-IJC1022>3.0.CO;2-D
Sarbia M, Gabbert HE. Modern pathology: prognostic parameters in squamous cell carcinoma of the esophagus. Recent Results Cancer Res 2000; 155: 15-27. http://dx.doi.org/10.1007/978-3-642-59600-1_2
Ruan S, Okcu MF, Pong RC, Andreeff M, Levin V, Hsieh JT, et al. Attenuation of WAF1/Cip1 expression by an antisense adenovirus expression vector sensitizes glioblastoma cells to apoptosis induced by chemotherapeutic agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. Clin Cancer Res 1999; 5: 197-202.
Wang Z, Sturgis EM, Zhang F, Lei D, Liu Z, Xu L, et al. Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck. Mol Cancer 2012; 11: 17. http://dx.doi.org/10.1186/1476-4598-11-17
Yang W, Qi Q, Zhang H, Xu W, Chen Z, Wang L, et al. p21 Waf1/Cip1 polymorphisms and risk of esophageal cancer. Ann Surg Oncol 2010; 17: 1453-8. http://dx.doi.org/10.1245/s10434-009-0882-x
Goubin F, Ducommun B. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene 1995; 10: 2281-7.
Mirzayans R, Andrais B, Scott A, Paterson MC, Murray D. Single-Cell Analysis of p16(INK4a) and p21(WAF1) Expression Suggests Distinct Mechanisms of Senescence in Normal Human and Li-Fraumeni Syndrome Fibroblasts. J Cell Physiol 2010; 223: 57-67.
Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 1996; 93: 13742-7. http://dx.doi.org/10.1073/pnas.93.24.13742
Wang D, Zhang YZ, Yang B, Zhang FX, Cao MY, Wang C, et al. p21 WAF1 and hypoxia/reoxygenation-induced premature senescence of H9c2 cardiomyocytes. Folia Histochem Cytobiol 2011; 49: 445-51. http://dx.doi.org/10.5603/FHC.2011.0063
Fan J, Wray J, Meng X, Shen Z. BCCIP is required for the nuclear localization of the p21 protein. Cell Cycle 2009; 8: 3019-24. http://dx.doi.org/10.4161/cc.8.18.9622
Qiu R, Wang S, Feng X, Chen F, Yang K, He S. Effect of subcellular localization of P21 on proliferation and apoptosis of HepG2 cells. J Huazhong Univ Sci Technol Med Sci 2011; 31: 756-61. http://dx.doi.org/10.1007/s11596-011-0672-0
Xia X, Ma Q, Li X, Ji T, Chen P, Xu H, et al. Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer. BMC Cancer 2011; 11: 399. http://dx.doi.org/10.1186/1471-2407-11-399
Vincent AJ, Ren S, Harris LG, Devine DJ, Samant RS, Fodstad O, et al. Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistance. FEBS Lett 2012; 586: 3429-34. http://dx.doi.org/10.1016/j.febslet.2012.07.063
Rossig L, Jadidi AS, Urbich C, Badorff C, Zeiher AM, Dimmeler S. Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol Cell Biol 2001; 21: 5644-57. http://dx.doi.org/10.1128/MCB.21.16.5644-5657.2001
Xia W, Chen JS, Zhou X, Sun PR, Lee DF, Liao Y, et al. Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients. Clin Cancer Res 2004; 10: 3815-24. http://dx.doi.org/10.1158/1078-0432.CCR-03-0527
Rodriguez-Vilarrupla A, Jaumot M, Abella N, Canela N, Brun S, Diaz C, et al. Binding of calmodulin to the carboxy-terminal region of p21 induces nuclear accumulation via inhibition of protein kinase C-mediated phosphorylation of Ser153. Mol Cell Biol 2005; 25: 7364-74. http://dx.doi.org/10.1128/MCB.25.16.7364-7374.2005
Agell N, Jaumot M, Rodriguez-Vilarrupla A, Brun S, Abella N, Canela N, et al. The diverging roles of calmodulin and PKC in the regulation of p21 intracellular localization. Cell Cycle 2006; 5: 3-6. http://dx.doi.org/10.4161/cc.5.1.2270
Scott MT, Ingram A, Ball KL. PDK1-dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein. EMBO J 2002; 21: 6771-80. http://dx.doi.org/10.1093/emboj/cdf684
Scott MT, Morrice N, Ball KL. Reversible phosphorylation at the C-terminal regulatory domain of p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding. J Biol Chem 2000; 275: 11529-37. http://dx.doi.org/10.1074/jbc.275.15.11529
Zhu H, Nie L, Maki CG. Cdk2-dependent Inhibition of p21 stability via a C-terminal cyclin-binding motif. J Biol Chem 2005; 280: 29282-8. http://dx.doi.org/10.1074/jbc.M407352200
Li Y, Dowbenko D, Lasky LA. AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem 2002; 277: 11352-61. http://dx.doi.org/10.1074/jbc.M109062200
Anttila MA, Kosma VM, Hongxiu J, Puolakka J, Juhola M, Saarikoski S, et al. p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. Br J Cancer 1999; 79: 1870-8. http://dx.doi.org/10.1038/sj.bjc.6690298
Lu X, Toki T, Konishi I, Nikaido T, Fujii S. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis. Cancer 1998; 82: 2409-17. http://dx.doi.org/10.1002/(SICI)1097-0142(19980615)82:12<2409::AID-CNCR15>3.0.CO;2-T
Hafkamp HC, Mooren JJ, Claessen SMH, Klingenberg B, Voogd AC, Bot FJ, et al. P21(Cip1/WAF1) expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. Modern Pathol 2009; 22: 686-98. http://dx.doi.org/10.1038/modpathol.2009.23
Hao H, Dong YB, Bowling MT, Zhou HS, McMasters KM. Alteration of gene expression in melanoma cells following combined treatment with E2F-1 and doxorubicin. Anticancer Res 2006; 26: 1947-56.
Dong YB, Yang HL, McMasters KM. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin. Cancer Gene Ther 2003; 10: 168-78. http://dx.doi.org/10.1038/sj.cgt.7700565
Yang K, Zheng XY, Qin J, Wang YB, Bai Y, Mao QQ, et al. Up-regulation of p21WAF1/Cip1 by saRNA induces G1-phase arrest and apoptosis in T24 human bladder cancer cells. Cancer Lett 2008; 265: 206-14. http://dx.doi.org/10.1016/j.canlet.2008.02.014
Tran PT, Fan AC, Bendapudi PK, Koh S, Komatsubara K, Chen J, et al. Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas. PLoS One 2008; 3: e2125. http://dx.doi.org/10.1371/journal.pone.0002125
Wu CH, van Riggelen J, Yetil A, Fan AC, Bachireddy P, Felsher DW. Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation. Proc Natl Acad Sci USA 2007; 104: 13028-33. http://dx.doi.org/10.1073/pnas.0701953104
Jeong JH, Kang SS, Park KK, Chang HW, Magae J, Chang YC. p53-independent induction of G1 arrest and p21WAF1/CIP1 expression by ascofuranone, an isoprenoid antibiotic, through downregulation of c-Myc. Mol Cancer Ther 2010; 9: 2102-13. http://dx.doi.org/10.1158/1535-7163.MCT-09-1159
Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445: 656-60. http://dx.doi.org/10.1038/nature05529
Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445: 661-5. http://dx.doi.org/10.1038/nature05541
Downloads
Published
How to Cite
Issue
Section
